Martek Announces First Quarter 2008 Financi... (uct sales in the first quarter increased...)

Martek Announces First Quarter 2008 Financial Results

Date:3/5/2008

uct sales in the first quarter increased 18% to $78.6 million reflecting continued strong demand from Martek's U.S. and international infant formula customers, the launch of new and growth of existing food and beverage products containing life'sDHA(TM) and the Company's increased penetration into its other non-infant formula nutritional markets.

Following is a breakdown of product sales by market for the first quarter (in thousands):

Three months ended January 31,

incr

2008 2007 (decr)

Infant formula market $ 70,278 $ 60,852 15%

Food and beverage market 2,095 721 191%

Pregnancy and nursing, nutritional

supplements and animal feeds 5,292 3,973 33%

Non-nutritional products 944 1,166 (19%)

Total product sales $ 78,609 $ 66,712 18%

New products launched during the first quarter co-branded with the Martek life'sDHA(TM) logo include:

Food and Beverage Products

-- Boost Juice's Pocket Rocket Juice with life'sDHA(TM) (Australia)

-- Dalco Foods' Wellness Line meat products with life'sDHA(TM) (Europe)

-- Parmalat Australia's Vaalia Low Fat Yoghurt and Vaalia Yoghurt for

Toddlers with life'sDHA(TM)

Pregnancy and Nursing Products

-- Azur Pharma's Natelle Plus with life'sDHA(TM) (United States)

Contract manufacturing sales totaled $4.3 million, compared with $3.5 million a year ago. These sales were higher than anticipated during the quarter due primarily to additional orders from one existing customer. The Company's contract manufacturing services continue to target only
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related medicine news :

1. Marteks lifesDHA(TM) Featured in Three New Offerings of Baby Food from Plum Organics
2. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
3. Pocket Rocket Juice from Australias Boost Juice Features 700 mg of Marteks lifesDHA(TM)
4. Martek Announces Settlement of Class Action Lawsuit
5. Marteks lifesDHA(TM) Featured in Dalco Foods Wellness Line Meat Products
6. Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International
7. Martek Wins German DHA Patent Infringement Actions Against Lonza and One of Nutrinovas Customers in Suits Relating to DHA Product Marketed for Use in Functional Foods and Dietary Supplements
8. Marteks lifesDHA(TM) Featured in New Beech-Nut(R) DHA Plus Baby Food and Cereals
9. Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
10. Martek Announces Addition of lifesDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars
11. Martek Announces Third Quarter 2007 Financial Results

Post Your Comments:

(Date:5/22/2013)... (PRWEB) May 22, 2013 According to a ... “Women Have More Options for Breast Cancer Surgery,” modern medical ... opportunity to approach this disease in a whole new light. ... developed, women now face breast cancer and mastectomies ... goo.gl/ARqoN). , “Before the introduction of plastic surgery to oncology, ...

(Date:5/22/2013)... genomic health disparities from the University of Miami Miller ... Medicine have teamed up to hold the second annual ... in Genomic Medicine." The theme of this year,s ... government to reduce these disparities. , Despite steady improvement ... within underserved groups continue to be more vulnerable to ...

(Date:5/22/2013)... 22, 2013 Award Presented at the ... press release here: http://bit.ly/13DkFfk , Merrill Corporation ... “Information Management Product/Service of the Year” at the 7th ... The Colony Hotel in Palm Beach, Florida. , ... room (VDR) solution that optimizes the due diligence ...

(Date:5/22/2013)... May 22, 2013 Registered Dietitian and Founder ... today on Tatalou.com sharing a recipe for making energy bars ... Healthy Energy Bars ,” takes a recipe modified from one ... twists. , “Every day it gets more and more difficult ... said Chevreau. “The size of the nutrition label continues to ...

(Date:5/22/2013)... 2013 Pamela Isom, President and CEO ... Business Journal’s 2013 Women of Influence Award in recognition ... , The reception took place on Thursday, May 2 ... Influence is particularly humbling for the 5,000 people ICE ... success is to recognize the four to nine lives ...

Breaking Medicine News(10 mins):Health News:Breast Augmentation – New Option for Breast Cancer Surgeries 2 Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2 Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2 Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3 Health News:How To "Make Your Own Healthy Energy Bars" 2 Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2

[0] Breast Augmentation – New Option for Breast Cancer Surgeries [0] Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine [0] Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year”[0] How To "Make Your Own Healthy Energy Bars"[0] Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award

... (HealthDay News) -- Teens undergoing treatment for alcohol or ... by groups such as Alcoholics Anonymous (AA) and Narcotics ... widely available, little research has looked at how effective ... 127 teen substance abuse-treatment outpatients (95 males, 32 females, ...

... April 16 (HealthDay News) -- Surgery for non-melanoma skin cancer ... mainly due to the increased use of a specific surgical ... in the outer layer of the skin or in skin ... according to the U.S. National Cancer Institute. More than ...

... Reinberg HealthDay Reporter , MONDAY, April 16 (HealthDay ... in the brains of people with multiple sclerosis (MS), researchers ... ONO-4641, "actually caused a reduction in relapses, which is somewhat ... said lead researcher Dr. Timothy Vollmer, a professor of neurology ...

... HealthDay Reporter , MONDAY, April 16 (HealthDay News) -- In a ... participated in the "choking game," in which blood and oxygen to ... produce a euphoric "high." What,s more, the researchers found that ... and many practiced other risky behaviors. "If kids do participate, ...

... Early symptoms of major mental illness can be ... be missed, or even ignored due to conventional wisdom ... deterioration and prolonged patterns of abnormality before diagnosing and ... waiting until someone is so ill that the psychological ...

... thought to play a crucial role in regulating cell proliferation. ... and interact with one another in intact animals., This study ... functional placenta and for balancing the effect of an E2F ... genes in a family of regulatory genes are vital for ...

Cached Medicine News:Health News:12-Step Meetings May Help Teens Beat Alcohol, Drug Abuse 2 Health News:Surgery Rates Rising for Non-Melanoma Skin Cancer: Study 2 Health News:Experimental Pill for Multiple Sclerosis Shows Promise 2 Health News:Experimental Pill for Multiple Sclerosis Shows Promise 3 Health News:Young Risk-Takers Drawn to Dangerous 'Choking Game' 2 Health News:Young Risk-Takers Drawn to Dangerous 'Choking Game' 3 Health News:First contact: Early intervention key in diagnosis and treatment of serious mental illness 2 Health News:2 repressor genes identified as essential for placental development 2

12-Step Meetings May Help Teens Beat Alcohol, Drug Abuse Surgery Rates Rising for Non-Melanoma Skin Cancer: Study Experimental Pill for Multiple Sclerosis Shows Promise Young Risk-Takers Drawn to Dangerous 'Choking Game'First contact: Early intervention key in diagnosis and treatment of serious mental illness 2 repressor genes identified as essential for placental development

(Date:5/22/2013)... TORONTO , May 22, 2013 /PRNewswire/ ... announced three presentations demonstrating the superiority of the AE37 ... Antigen Express, Inc. ( www.antigenexpress.com ). The presentations will ... Society of Clinical Oncology (ASCO) to be held in ... June 4, 2013. The presentation entitled " ...

(Date:5/22/2013)... , 22. Mai 2013 Grifols, ein ... Barcelona , Spanien, präsentierte ... eine höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) ... Alpha1-Antitrypsinmangel (AAT) auf ein Niveau anhebt, das ... Bereichs liegt. ATT-Mangel ist eine lebensbedrohliche, genetische ...

(Date:5/22/2013)... , May 22, 2013 Medifocus, Inc. (OTCQX: MDFZF and ... , Chief Operating Officer, will present at the Second Annual ... New York City at the Grand ... to begin at 4:00 p.m. EDT and will be available ... http://wsw.com/webcast/marcum/mfs.v/ For more information and registration, ...

Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4 Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2 Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3

[0] Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine [0] Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt [0] Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference

... 48-week investigational regimen yielded nearly double SVR rate ... protease inhibitor SCH 900518 presented at EASL annual ... SGP ) today reported that final ... its investigational oral hepatitis C protease inhibitor, in ...

... Potential of Fully Human Anti-PS Antibodies and ... Equivalent to the Human Antibody Inhibited Tumor ... More than 90%-DENVER and TUSTIN, Calif., April ... PPHM), a clinical stage biopharmaceutical company ...

Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrine's Fully Human Anti-PS Antibody in Prostate Cancer Model

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Thyroxine Thyroid Stimulating Hormone Ultrasensitive Thyroid Stimulating Hormone Thyroid Releasing Hormone (TRH) Stimulation of Prolactin, 60 Minutes